US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist
  • 0.560
  • +0.056+11.08%
Close Jul 22 16:00 ET
  • 0.555
  • -0.005-0.80%
Post 16:41 ET
43.70MMarket Cap-532P/E (TTM)

Aligos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Aligos Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 7, 2024

Revenue(YoY)

986.00K

-63.79%
EPS(YoY)

-0.22

+58.49%
Analyst Rating

Buy

Jun 30, 2024

Aligos Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 7, 20242024/Q1986.000K / 0.000--
Mar 12, 20242023/Q42.009M / 1.600M--
Nov 2, 20232023/Q33.239M / 2.500M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 7, 20242024/Q1986.000K / 0.000--
Mar 12, 20242023/Q42.009M / 1.600M--
Nov 2, 20232023/Q33.239M / 2.500M--

Unlock Free Earnings Estimates

Aligos Therapeutics Earnings Reports

  • Aligos Therapeutics | 10-Q: Quarterly report

    May 7 16:52 ET

  • Aligos Therapeutics | 10-K: Annual report

    Mar 12 16:19 ET

  • Aligos Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 16:23 ET

  • Aligos Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 3, 2023 16:21 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg